This increase appears to be breast cancer-specific since IL-6 levels were equal in serum and interstitial tissue of non-tumor bearing Chy and wt mice [12], and in KHT-1 tumors with or without the Chy mutation. The gene discussed is IL6; the disease is breast carcinoma.